Cascadian Therapeutics Inc (NASDAQ:CASC)

10.00
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
3.18
Today|||52-Week Range
10.21
+170.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization489.0K512.0K613.0K642.0K
 
 
 
 
 
 
Operating ExpensesGross Income-489.0K-512.0K-613.0K-642.0K
 
 
 
 
 
General Expenses40.7M49.8M32.2M46.0M
 
 
 
 
 
Research And Development33.2M41.9M23.5M29.0M
 
 
 
 
 
Total Operating Expenses41.2M50.3M32.8M46.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-41.2M-50.3M-32.8M-46.6M
 
 
 
 
 
Extraordinary Credit2.3M796.0K128.0K1.5M
 
 
 
 
 
Extraordinary Charge0.00-500.0K0.00-19.7M
 
 
 
Other Expenses42.0K3.0K7.0K-18.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.8M-50.0M-32.6M-64.6M
 
 
 
 
 
Income Taxes0.000.000.00-6.9M
 
 
Preferred Dividend0.000.000.00-2.6M
 
 
Net Income-38.8M-50.0M-32.6M-57.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS62.4M77.6M96.6M19.3M
 
 
 
 
 
Shares To Calculate EPS Diluted62.4M77.6M96.6M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$0.64-$0.34-$3.13
 
 
 
 
 
EPS Diluted-$0.62-$0.64-$0.34-$3.13